Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors

Table 3

Comparison of the qualitative features between the two groups.

	Group C	Group R	t	P
Age	53.5 ± 10.14	45 ± 15.07	1.429	0.172
Duration of symptom (months)	11.08 ± 13.68	3.88 ± 3.6	1.597	0.14
Follow-up time (months)	15.44 ± 11.96	16.25 ± 13.07	−0.133	0.896
Axial length (mm)	23.03 ± 0.75	23.57 ± 0.65	−1.558	0.14
Spherical equivalent (D)	0.64 ± 1.65	−0.63 ± 1.41	1.687	0.112
Intraocular pressure (mmHg)	14.7 ± 3.19	13.85 ± 3.18	0.549	0.591
BCVA (logMAR)
Pre-op	0.49 ± 0.62	1.19 ± 0.75	−2.097	0.053
Post-op 6 months	0.52 ± 0.64	0.33 ± 0.31	0.824	0.426
Last	0.47 ± 0.56	0.43 ± 0.31	0.192	0.851
Post-op 6m vs pre-op	0.03 ± 0.43	−0.86 ± 0.70	3.201	0.006^∗
Last vs post-op 6m	−0.06 ± 0.14	0.10 ± 0.13	−2.398	0.03^∗
Last vs pre-op	−0.03 ± 0.48	−0.76 ± 0.73	2.407	0.033^∗